Last reviewed · How we verify

NCT03433287

Chronic Recurrent Multifocal Osteomyelitis - a Bacterial Cause?

Status unknown NA Last updated 24 May 2022
What this trial tests

NA trial testing 18F-NaF-PET/MRI in Chronic Recurrent Multifocal Osteomyelitis in 15 participants. Status unknown.

Timeline
1 November 2015
Primary endpoint
1 January 2022
1 December 2022

Quick facts

Lead sponsorRigshospitalet, Denmark
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment15
Start date1 November 2015
Primary completion1 January 2022
Estimated completion1 December 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

Adults 0 to 18, any sex, with Chronic Recurrent Multifocal Osteomyelitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic recurrent multifocal osteomyelitis (CRMO) is an immune-mediated chronic inflammatory self- limiting disease with non-suppurative inflammation involving one or multiple bone foci. A bacterial etiology has not yet been proven, but the investigators hypothesize that CRMO is caused by chronic infection. Using existing knowledge of chronic infections combined with sensitive molecular techniques, the hope is to elucidate the cause of CRMO by proving or disproving bacteria as the underlying etiology. In addition, a novel method, 18F-NaF-PET/MRI, will be investigated as to which it can improve diagnosis of CRMO. The investigators hypothesize that 18F-NaF-PET/MRI will have higher diagnostic accuracy than 99m-diphosphonate planar bone scintigraphy and SPECT/CT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Recurrent Multifocal Osteomyelitis

Currently open trials in the same condition.

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03433287.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing